Notice of Meeting: Secretary's Advisory Committee on Genetics, Health, and Society, 5675 [06-978]
Download as PDF
<![CDATA[
Federal Register / Vol. 71, No. 22 / Thursday, February 2, 2006 / Notices
fulfill the purpose and need to provide
national biocontainment facilities. Other
relevant factors included in the
decision, such as NIAID’s mandate to
conduct and support research on agents
of emerging and re-emerging infectious
diseases, were carefully considered.
Dated: January 26, 2006.
Juanita M. Mildenberg,
FAIA Acting Director, Office of Research
Facilities Development and Operations,
National Institutes of Health.
[FR Doc. E6–1402 Filed 2–1–06; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
hsrobinson on PROD1PC71 with NOTICES
Notice of Meeting: Secretary’s
Advisory Committee on Genetics,
Health, and Society
Pursuant to Public Law 92–463,
notice if hereby given of the ninth
meeting of the Secretary’s Advisory
Committee on Genetics, Health, and
Society (SACGHS), U.S. Public Health
Service. The meeting will be held from
9 a.m. to 5 p.m. on March 27, 2006 and
9 a.m. to 5 p.m. on March 28, 2006 at
the National Institutes of Health,
Building 31, C Wing, Conference Room
6, 31 Center Drive, Bethesda, MD 20892.
The meeting will be open to the public
with attendance limited to space
available. The meeting will be webcast.
The first day of the meeting will
include sessions on pharmacogenomics
and large population studies of genetic
variation, the environment and common
disease. The pharmacogenomics session
will include a review of Federal efforts
in pharmacogenomics and deliberation
on draft recommendations in this area.
The large population studies session
will involve discussion of a draft report
that identifies policy issues associated
with mounting a large population study
in the United States.
The second day will be devoted to
sessions on genetic discrimination and
patents and licensing issues. The
genetic discrimination session will
include an update on the status of
Federal genetic non-discrimination
legislation. The patents and licensing
session will involve a presentation on
the findings and conclusions of a
National Academy of Sciences’ report
on intellectual property rights in
genomic research and innovation, and a
discussion on whether there are other
issues in this arena that warrant
SACGHS’s further attention.
Time will be provided each day for
public comments. The Committee
VerDate Aug<31>2005
15:26 Feb 01, 2006
Jkt 208001
would welcome hearing from anyone
wishing to provide public comment on
any issue related to genetics, health and
society. Individuals who would like to
provide public comment or who plan to
attend the meeting and need special
assistance, such as sign language
interpretation or other reasonable
accommodations, should notify the
SACGHS Executive Secretary, Ms. Sarah
Carr, by telephone at 301–496–9838 or
e-mail at sc112@nih.gov. The SACGHS
office is located at 6705 Rockledge
Drive, Suite 750, Bethesda, MD 20892.
Under authority of 42 U.S.C. 217a,
Section 222 of the Public Health Service
Act, as amended, the Department of
Health and Human Services established
SACGHS to serve as a public forum for
deliberations on the broad range of
human health and societal issues raised
by the development and use of genetic
technologies and, as warranted, to
provide advice on these issues. The
draft meeting agenda and other
information about SACGHS, including
information about access to the webcast
will be available at the following Web
site: https://www4.od.nih.gov/oba/
sacghs.htm.
Dated: January 26, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–979 Filed 2–1–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Notice of Meeting: Secretary’s
Advisory Committee on Genetics,
Health, and Society
Pursuant to Public Law 92–463,
notice is hereby given of the ninth
meeting of the Secretary’s Advisory
Committee on Genetics, Health, and
Society (SACGHS), U.S. Public Health
Service. The meeting will be held from
9 a.m. to 5 p.m. on March 27, 2006 and
9 a.m. to 5 p.m. on March 28, 2006 at
the National Institutes of Health,
Building 31, C Wing, Conference Room
6, 31 Center Drive, Bethesda, MD 20892.
The meeting will be open to the public
with attendance limited to space
available. The meeting will be webcast.
The first day of the meeting will
include sessions on pharmacogenomics
and large population studies of genetic
variation, the environment and common
disease. The pharmacogenomics session
will include a review of Federal efforts
in pharmacogenomics and deliberation
on draft recommendations in this area.
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
5675
The large population studies session
will involve discussion of a draft report
that identifies policy issues associated
with mounting a large population study
in the United States.
The second day will be devoted to
sessions on genetic discrimination and
patents and licensing issues. The
genetic discrimination session will
include an update on the status of
Federal genetic non-discrimination
legislation. The patents and licensing
session will involve a presentation on
the findings and conclusions of a
National Academy of Sciences report on
intellectual property rights in genomic
research and innovation, and a
discussion of whether there are other
issues in this area that warrant
SACGHS’s further attention.
Time will be provided each day for
public comments. The Committee
would welcome hearing from anyone
wishing to provide public comment on
any issue related to genetics, health and
society. Individuals who would like to
provide public comment or who plan to
attend the meeting and need special
assistance, such as sign language
interpretation or other reasonable
accommodation, should notify the
SACGHS Executive Secretary, Ms. Sarah
Carr, by telephone at 301–496–9838 or
e-mail at sc112c@nih.gov. The SACGHS
office is located at 6705 Rockledge
Drive, Suite 750, Bethesda, MD 20892.
Under authority of 42 U.S.C. 217a,
Section 222 of the Public Health Service
Act, as amended, the Department of
Health and Human Services established
SACGHS to serve as a public forum for
deliberations on the broad range of
human health and societal issues raised
by the development and use of genetic
technologies and, as warranted, to
provide advice on these issues. The
draft meeting agenda and other
information about SACGHS, including
information about access to the webcast
will be available at the following Web
site: https://www4.od.nih.gov/oba/
sacghs.htm.
Dated: January 26, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–978 Filed 2–1–06; 8:45 am]
BILLING CODE 4140–01–M
E:\FR\FM\02FEN1.SGM
02FEN1
]]>Agencies
[Federal Register Volume 71, Number 22 (Thursday, February 2, 2006)]
[Notices]
[Page 5675]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-978]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Notice of Meeting: Secretary's Advisory Committee on Genetics,
Health, and Society
Pursuant to Public Law 92-463, notice is hereby given of the ninth
meeting of the Secretary's Advisory Committee on Genetics, Health, and
Society (SACGHS), U.S. Public Health Service. The meeting will be held
from 9 a.m. to 5 p.m. on March 27, 2006 and 9 a.m. to 5 p.m. on March
28, 2006 at the National Institutes of Health, Building 31, C Wing,
Conference Room 6, 31 Center Drive, Bethesda, MD 20892. The meeting
will be open to the public with attendance limited to space available.
The meeting will be webcast.
The first day of the meeting will include sessions on
pharmacogenomics and large population studies of genetic variation, the
environment and common disease. The pharmacogenomics session will
include a review of Federal efforts in pharmacogenomics and
deliberation on draft recommendations in this area. The large
population studies session will involve discussion of a draft report
that identifies policy issues associated with mounting a large
population study in the United States.
The second day will be devoted to sessions on genetic
discrimination and patents and licensing issues. The genetic
discrimination session will include an update on the status of Federal
genetic non-discrimination legislation. The patents and licensing
session will involve a presentation on the findings and conclusions of
a National Academy of Sciences report on intellectual property rights
in genomic research and innovation, and a discussion of whether there
are other issues in this area that warrant SACGHS's further attention.
Time will be provided each day for public comments. The Committee
would welcome hearing from anyone wishing to provide public comment on
any issue related to genetics, health and society. Individuals who
would like to provide public comment or who plan to attend the meeting
and need special assistance, such as sign language interpretation or
other reasonable accommodation, should notify the SACGHS Executive
Secretary, Ms. Sarah Carr, by telephone at 301-496-9838 or e-mail at
sc112c@nih.gov. The SACGHS office is located at 6705 Rockledge Drive,
Suite 750, Bethesda, MD 20892.
Under authority of 42 U.S.C. 217a, Section 222 of the Public Health
Service Act, as amended, the Department of Health and Human Services
established SACGHS to serve as a public forum for deliberations on the
broad range of human health and societal issues raised by the
development and use of genetic technologies and, as warranted, to
provide advice on these issues. The draft meeting agenda and other
information about SACGHS, including information about access to the
webcast will be available at the following Web site: https://
www4.od.nih.gov/oba/sacghs.htm.
Dated: January 26, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-978 Filed 2-1-06; 8:45 am]
BILLING CODE 4140-01-M
